Esperion to Present at the CIBC World Markets Healthcare Conference
November 10 2003 - 5:00PM
PR Newswire (US)
Esperion to Present at the CIBC World Markets Healthcare Conference
ANN ARBOR, Mich., Nov. 10 /PRNewswire-FirstCall/ -- Esperion
Therapeutics, Inc. , a biopharmaceutical company dedicated to the
discovery, development and commercialization of therapies to
improve the treatment of cardiovascular disease, today announced
that Roger S. Newton, Ph.D., will present at the CIBC World Markets
Healthcare Conference on Wednesday, November 12, 2003 in New York
City. Dr. Newton is scheduled to speak at 2:30 p.m. (ET). Investors
and others may access a live audio webcast of the presentation at
http://www.esperion.com/ by first clicking the Investor Relations
link and then clicking the Calendar link. A webcast replay of the
Esperion presentation may be accessed until December 12, 2003 by
first clicking the Investor Relations link and then clicking the
Audio/Visual Archives link. Esperion Therapeutics Esperion
Therapeutics, Inc. discovers and develops pharmaceutical products
for the treatment of cardiovascular disease. Esperion intends to
commercialize a novel class of drugs that focuses on a new
treatment approach called "HDL Therapy," which is based on the
Company's understanding of high- density lipoprotein, or HDL,
function. HDL is the primary facilitator of the reverse lipid
transport, or RLT, pathway by which excess cholesterol and other
lipids are removed from artery walls and other tissues and are
transported to the liver for elimination from the body. Esperion's
goal is to develop drugs that exploit the beneficial functions of
HDL within the RLT pathway. Esperion currently has four product
candidates in clinical development. Esperion is listed on the
Nasdaq National Market under the symbol "ESPR." Company Contact:
Amy Cannon Manager, Corporate Communications Esperion Therapeutics,
Inc. (734) 222-1801 DATASOURCE: Esperion Therapeutics, Inc.
CONTACT: Amy Cannon, Manager, Corporate Communications of Esperion
Therapeutics, Inc., +1-734-222-1801, Web site:
http://www.esperion.com/
Copyright
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024